Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies
Authors
Keywords
-
Journal
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
Volume 45, Issue 7, Pages 1111-1119
Publisher
Informa UK Limited
Online
2019-04-01
DOI
10.1080/03639045.2019.1593444
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study
- (2018) Ola M. Abdallah et al. BIOMEDICAL CHROMATOGRAPHY
- Drug Interchangeability of Generic and Brand Products of Fixed Dose Combination Tablets of Sofosbuvir and Ledipasvir (400/90 mg): Employment of Reference Scaled Average Bioequivalence Study on Healthy Egyptian Volunteers
- (2018) Ehab Rasmy Bendas et al. CLINICAL DRUG INVESTIGATION
- Drug–Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/Sofosbuvir
- (2018) Polina German et al. CLINICAL PHARMACOKINETICS
- Validated HPLC–DAD Method for the Simultaneous Determination of Six Selected Drugs Used in the Treatment of Glaucoma
- (2018) Mostafa M. Baker et al. JOURNAL OF AOAC INTERNATIONAL
- Investigation of anti-Hepatitis C virus, sofosbuvir and daclatasvir, in pure form, human plasma and human urine using micellar monolithic HPLC-UV method and application to pharmacokinetic study
- (2018) Dalia W. Zidan et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- New, simple and sensitive HPTLC method for simultaneous determination of anti-hepatitis C sofosbuvir and ledipasvir in rabbit plasma
- (2018) Samia M. El-Gizawy et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- UPLC–MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients
- (2018) Stefania Notari et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Simultaneous quantitation of two direct acting hepatitis C antivirals (sofosbuvir and daclatasvir) by an HPLC-UV method designated for their pharmacokinetic study in rabbits
- (2018) Noha N. Atia et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Comparison between core-shell and totally porous particle stationary phases for fast and green LC determination of five hepatitis-C antiviral drugs
- (2018) Adel Ehab Ibrahim et al. JOURNAL OF SEPARATION SCIENCE
- Comparative study of six sequential spectrophotometric methods for quantification and separation of ribavirin, sofosbuvir and daclatasvir: An application on Laboratory prepared mixture, pharmaceutical preparations, spiked human urine, spiked human plasma, and dissolution test
- (2018) Wafaa S. Hassan et al. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- A new innovative spectrophotometric method for the simultaneous determination of sofosbuvir and ledipasvir
- (2018) Fotouh R. Mansour SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- Earth-friendly spectrophotometric methods for simultaneous determination of ledipasvir and sofosbuvir: Application to average content and uniformity of dosage unit testing
- (2018) Hanan I. EL-Shorbagy et al. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- Large-scale hepatitis C combating campaigns in Egypt and Georgia; past, current and future challenges
- (2018) Fatma Abdelaziz Amer Journal of Infection in Developing Countries
- Pharmacodynamic and pharmacokinetic evaluation of the combination of daclatasvir/sofosbuvir/ribavirin in the treatment of chronic hepatitis C
- (2018) Antonio Rivero-Juarez et al. Expert Opinion on Drug Metabolism & Toxicology
- A Stability-Indicating UPLC Method for the Determination of Potential Impurities and Its Mass by a New QDa Mass Detector in Daclatasvir Drug Used to Treat Hepatitis C Infection
- (2018) Varaprasad Jagadabi et al. JOURNAL OF CHROMATOGRAPHIC SCIENCE
- Development of a highly sensitive high-performance thin-layer chromatography method for the screening and simultaneous determination of sofosbuvir, daclatasvir, and ledipasvir in their pure forms and their different pharmaceutical formulations
- (2018) Roshdy E. Saraya et al. JOURNAL OF SEPARATION SCIENCE
- Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma: Clinical Application to Therapeutic Drug Monitoring
- (2018) Naser F. Al-Tannak et al. International Journal of Analytical Chemistry
- Spectrophotometric Methods for Simultaneous Determination of Sofosbuvir and Ledipasvir (HARVONI Tablet): Comparative Study with Two Generic Products
- (2017) Nisreen F. Abo-Talib et al. JOURNAL OF AOAC INTERNATIONAL
- Chromatographic analysis of ledipasvir and sofosbuvir: New treatment for chronic hepatitis C infection with application to human plasma
- (2017) Nehal F. Farid et al. JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
- Development a validated highly sensitive LC–MS/MS method for simultaneous quantification of Ledipasvir, sofosbuvir and its major metabolite GS-331007 in human plasma: Application to a human pharmacokinetic study
- (2017) Ola M. Abdallah et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Simultaneous determination of the brand new two-drug combination for the treatment of hepatitis C: Sofosbuvir/ledipasvir using smart spectrophotometric methods manipulating ratio spectra
- (2017) Maya S. Eissa SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- A Rapid and Optimized LC-MS/MS Method for the Simultaneous Extraction and Determination of Sofosbuvir and Ledipasvir in Human Plasma
- (2016) Ehab F. Elkady et al. JOURNAL OF AOAC INTERNATIONAL
- Stability-Indicating Method and LC–MS-MS Characterization of Forced Degradation Products of Sofosbuvir
- (2016) M. Nebsen et al. JOURNAL OF CHROMATOGRAPHIC SCIENCE
- Characterization of forced degradation products and in silico toxicity prediction of Sofosbuvir: A novel HCV NS5B polymerase inhibitor
- (2016) Debasish Swain et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- High-performance liquid chromatography with diode array detection method for the simultaneous determination of seven selected phosphodiesterase-5 inhibitors and serotonin reuptake inhibitors used as male sexual enhancers
- (2016) Mostafa M. Baker et al. JOURNAL OF SEPARATION SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search